Musculoskeletal Disorders

Part A: The Skeleton
  • R D C Brackenridge
  • Geoffrey H Robb


Although some bone lesions have a purely local pathology, disorders of the skeleton, as of the skin, frequently reflect a more widespread pathological process. In some deformities, such as those caused by infantile rickets, the systemic disorder is a thing of the past, the only remaining evidence being skeletal changes. On the other hand, a primary bone disease may give rise to systemic effects; for example, extensive Paget’s disease of bone can cause a profound hemodynamic disturbance leading to high-output congestive cardiac failure. Excluding malignant tumors, skeletal disorders that are not part of a primary systemic disease would usually have little effect by themselves on longevity unless there was anatomical interference with vital structures, such as pressure effects on nervous tissue or on the heart or lungs.


Chronic Fatigue Syndrome Osteogenesis Imperfecta Musculoskeletal Disorder Fibrous Dysplasia Marfan Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Medical Impairment Study 1983. Vol 1. Boston: Society of Actuaries and Association of Life Insurance Medical Directors of America, 1986.Google Scholar
  2. 2.
    Harrison JE. Osteoporosis: new ideas for an old problem. Trans Assoc Life Ins Med Dir Am 1986; 70: 53–71.Google Scholar
  3. 3.
    Duursma SA. Osteoporosis. Trans Assoc Life Ins Med Dir Am 1989; 73: 115–20.Google Scholar
  4. 4.
    Paterson CR, Ogston SA, Henry RM. Life expectancy in osteogenesis imperfecta. BMJ 1996; 312: 351.PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Ratcliffe AHC. J Bone Joint Surg 1967; 49B: 102.Google Scholar
  6. 6.
    Nachemson A. A long term follow-up study of non-treated scoliosis. Acta Orthop Scand 1968; 39: 456.CrossRefGoogle Scholar
  7. 7.
    Nilsonne U, Lundgren K-D. Long term prognosis in idiopathic scoliosis. Acta Orthop Scand 1968, 39: 456.CrossRefPubMedGoogle Scholar
  8. 8.
    1951 Impairment Study. New York: Society of Actuaries, 1954.Google Scholar
  9. 9.
    Singer RB, Levinson L. Medical Risks: patterns of mortality and survival. Lexington: DC Heath, 1976.Google Scholar
  10. 10.
    Lew EA, Gajewski J (eds). Medical Risks: trends in mortality by age and time elapsed. Vol 2. New York: Praeger, 1990.Google Scholar
  11. 1.
    Schrader H et al. Natural evolution of late whiplash syndrome outside the medicolegal context. Lancet 1996; 347: 1207–11CrossRefPubMedGoogle Scholar
  12. 2.
    Williams R, Westmorland M. Occupational cumulative trauma disorders of the upper extremity. J Occup Med 1994; 48: 411–20.Google Scholar
  13. 3.
    Yu ITS, Wong TW. Musculoskeletal problems among VDU workers in a Hong Kong bank. Occup Med 1996; 46: 275–80.CrossRefGoogle Scholar
  14. 4.
    Hopkins A. The social recognition of repetition strain injuries: an Australian/American comparison. Soc Sci Med 1990; 30: 365–72.CrossRefPubMedGoogle Scholar
  15. 5.
    Moldofsky H et al. Musculoskeletal symptoms and non- REM sleep disturbance in patients with ‘fibrositis syndrome’ and healthy subjects. Psychosom Med 1975;31: 341–51.CrossRefGoogle Scholar
  16. 6.
    Yunus MB et al. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981; 11: 151–71.CrossRefPubMedGoogle Scholar
  17. 7.
    Wolfe F and the Vancouver Fibromyalgia Consensus Group. The fibromyalgia syndrome: a consensus report on fibromyalgia and disability. J Rheumatol 1996; 23(3): 534–37.Google Scholar
  18. 8.
    Wolfe F et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160–72.CrossRefPubMedGoogle Scholar
  19. 9.
    Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991; 18(5): 728–33.PubMedGoogle Scholar
  20. 10.
    Stanton-Hicks M et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 1995; 63: 127–33.CrossRefPubMedGoogle Scholar
  21. 11.
    Poplawski ZJ, Wiley AM, Murray JF. Post traumatic dystrophy of the extremities: a review and trial of treatment. J Bone Joint Surg AM 1983; 65: 642–54.PubMedGoogle Scholar
  22. 12.
    Ide J et al. Quantitative evaluation of sympathetic nervous system dysfunction in patients with reflex sympathetic dystrophy. J Hand Surg 1997; 22B: 102–6.CrossRefGoogle Scholar
  23. 13.
    Hanna MH, Peat SJ. Ketanserin in reflex sympathetic dystrophy: a double blind placebo controlled cross-over trial. Pain 1989; 38: 145–50.CrossRefPubMedGoogle Scholar

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Limited 2000

Authors and Affiliations

  • R D C Brackenridge
  • Geoffrey H Robb

There are no affiliations available

Personalised recommendations